Literature DB >> 26055280

[Allogeneic parathyroid: 2-year follow-up].

José Manuel Hermosillo-Sandoval1, Karla Lisseth Leonher-Ruezga1, José Alfredo Jiménez-Gómez1, Clotilde Fuentes-Orozco2, Alejandro González-Ojeda2, Luis Ricardo Ramírez-González3.   

Abstract

BACKGROUND: Hypoparathyroidism is one of the most frequent complications of neck surgery. The treatment is currently medical; however this involves several complications secondary to high doses of calcium and vitamin D, thus making parathyroid allotransplantation a good management option.
MATERIAL AND METHODS: Patients with hypoparathyroidism were selected in the April-December period of 2011 in the general surgical clinic. They were between 16 and 65 years, and ingested high doses of calcium. The donors were patients with primary and secondary hyperparathyroidism, and the transplants were performed in relation to blood group and human leucocyte antigen.
RESULTS: Five parathyroid allografts were performed. All the patients had iatrogenic hypoparathyroidism, all women with a mean age of 49.8 years. The graft was implanted under local anaesthesia in the non-dominant forearm. Four of the patients are so far considered functional due to the increase in paratohormone, and demonstrating its function by scintigraphy with sestamibi. One of the patients showed no increase in paratohormone or imaging studies that demonstrate its functionality. After a two year follow up the graft remains functional but with with oral calcium intake at a lower dose than before transplantation. None of the patients had immunosuppression side effects.
CONCLUSIONS: In this study, allogeneic unrelated living parathyroid transplant with an immunosuppressive regimen of six months has proven to be a safe alternative treatment to improve quality of life by decreasing the excessive calcium intake and improving physical activity with adequate graft survival at 24 months follow up.
Copyright © 2015 Academia Mexicana de Cirugía A.C. Published by Masson Doyma México S.A. All rights reserved.

Entities:  

Keywords:  Allotrasplant; Alotrasplante; Hipocalcemia; Hipoparatiroidismo; Hypocalcaemia; Hypoparathyroidism; Parathyroid; Paratiroides

Mesh:

Year:  2015        PMID: 26055280     DOI: 10.1016/j.circir.2015.05.002

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  3 in total

1.  Living-donor parathyroid allotransplantation for therapy-refractory postsurgical persistent hypoparathyroidism in a nontransplant recipient - three year results: a case report.

Authors:  Ayman Agha; Marcus Nils Scherer; Christian Moser; Thomas Karrasch; Christiane Girlich; Fabian Eder; Ernst-Michael Jung; Hans Juergen Schlitt; Andreas Schaeffler
Journal:  BMC Surg       Date:  2016-08-03       Impact factor: 2.102

Review 2.  MANAGEMENT OF ENDOCRINE DISEASE: Postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantation.

Authors:  Radu Mihai; Rajesh V Thakker
Journal:  Eur J Endocrinol       Date:  2021-05       Impact factor: 6.664

Review 3.  Parathyroid Allotransplantation: A Systematic Review.

Authors:  Jaimie L H Zhang; Natasha M Appelman-Dijkstra; Abbey Schepers
Journal:  Med Sci (Basel)       Date:  2022-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.